NEOGENOMICS INC — Director's Dealing 2021

Jun 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-06-11

Reporting Person: TETRAULT LYNN A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-11	Common Stock	M	1389	$9.11	Acquired	34939	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-11	Stock Option (Right to Buy)	$9.11	M	1389	Disposed	2021-07-28	Common Stock (1389.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.27	2022-05-25	Common Stock (3334.0)	3334	Direct
Stock Options (Right to Buy)	$11.6	2023-06-01	Common Stock (1507.0)	1507	Direct
Stock Option (Right to Buy)	$22.52	2026-06-06	Common Stock (2136.0)	2136	Direct
Stock Option (Right to Buy)	$28.54	2027-05-28	Common Stock (3448.0)	3448	Direct
Stock Option (Right to Buy)	$40.9	2028-06-02	Common Stock (3714.0)	3714	Direct

Footnotes

F1: On July 28, 2016, Lynn Tetrault was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F2: On May 25, 2017, Lynn Tetrault was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.